AfterBRCA1, the most significant association for ER Negative disease in the gene burden analysis was forCYP2C18which overlapsCYP2C19(ER-negative OR = 2.6,P = 0.002; triple-negative OR = 4.4,P = 0.0002). A previous analysis of CNVs and breast cancer in the Finnish populat...